Abnova (Taiwan) Corporation (TPE:4133)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.45
-0.05 (-0.22%)
Apr 20, 2026, 1:21 PM CST
Market Cap1.36B -26.4%
Revenue (ttm)351.30M -1.1%
Net Income-1.14M
EPS-0.02
Shares Out60.55M
PE Ration/a
Forward PEn/a
Dividend0.11 (0.50%)
Ex-Dividend DateJun 16, 2025
Volume32,818
Average Volume81,206
Open22.55
Previous Close22.50
Day's Range22.40 - 22.75
52-Week Range22.15 - 35.10
Beta0.51
RSI39.95
Earnings DateApr 2, 2026

About Abnova (Taiwan)

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company’s products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, Nano, DNAxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4133
Full Company Profile

Financial Performance

Financial Statements